Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Quethera

2013 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$111M LATEST DEAL AMOUNT
Description

Developer of gene therapy technologies designed to improve the future treatment of common blinding eye diseases. The company's technologies focus on the development of therapies that reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve, enabling patients to get efficient treatment for their eye diseases and recover faster.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • The Babraham Institute, Babraham Hall House
  • Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Quethera’s full profile, request a free trial.

Quethera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 10-Aug-2018 $111M 00000 00000 Completed Generating Revenue
3. Grant 07-Mar-2016 00000 00000 Completed Startup
2. Early Stage VC 07-Aug-2015 $625K $625K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Quethera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view this company’s complete Cap Table, request access »

Quethera Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MiNA Therapeutics Venture Capital-Backed London, United Kingdom 00 000.00 0000000000 0 000.00
000000 00000000 Formerly VC-backed Palo Alto, CA 00 00000 00000000 00000
0000000 Venture Capital-Backed Cambridge, United Kingdom 00 00.000 0000000000 0 00.000
000 000000000000 Venture Capital-Backed Ann Arbor, MI 0 000.00 000000 0
0000000 000000 Venture Capital-Backed Redwood City, CA 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Quethera Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Babraham Bioscience Technologies Accelerator/Incubator 000 0000 000000 0
Cambridge Enterprise Angel Group Minority 000 0000 000000 0
Midven (Birmingham) Venture Capital Minority 000 0000 000000 0
Parkwalk Advisors Venture Capital Minority 000 0000 000000 0
UK Innovation & Science Seed Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Quethera Executive Team (2)

Name Title Board
Seat
Contact
Info
Keith Martin Chief Scientific Officer
Peter Widdowson Ph.D Co-Founder, Board Member & Chief Executive Officer

Quethera Board Members (3)

Name Representing Role Since Contact
Info
Peter Widdowson Ph.D Self Co-Founder, Board Member & Chief Executive Officer 000 0000

2 Former Board Members

You’re viewing 1 of 3 board members. Get the full list »